Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-4597 inhalation in he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-4597 inhalation (SHR-4597)

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Healthy Subjects, Asthmatic Patients | Phase 1 | Status: COMPLETED